D.C. Circuit: Merck Can’t Pull the Rug Out From Under Para IV Listers
Ranbaxy and Teva won a victory in the U.S. Court of Appeals for the D.C. Circuit that preserved their 180-day exclusivity when patents are delisted
http://www.patentbaristas.com/archives/000…
Technorati Tags: patent, patents



